Works matching IS 15330028 AND DT 2013 AND VI 12 AND IP 2
Results: 9
Adverse Events Associated With Antiangiogenic Agents in Combination With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer and Their Management.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 2, p. 86, doi. 10.1016/j.clcc.2012.12.001
- By:
- Publication type:
- Article
Targeted Therapy for Metastatic Colorectal Cancer: Role of Aflibercept.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 2, p. 73, doi. 10.1016/j.clcc.2012.08.001
- By:
- Publication type:
- Article
Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Impact of a Dedicated Cancer Center Surveillance Program on Guideline Adherence for Patients With Stage II and III Colorectal Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A Combined Analysis of Mismatch Repair Status and Thymidylate Synthase Expression in Stage II and III Colon Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Looks like lung cancer acts like colon cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Multiorgan failure in a patient treated with the 5-Fluorouracil, leucovorin, oxaliplatin, and irinotecan regimen.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Geographic Variation and Sociodemographic Disparity in the Use of Oxaliplatin-Containing Chemotherapy in Patients With Stage III Colon Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article